Nika Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NIKA research report →
About the company
Nika Pharmaceuticals Inc. , a pharmaceutical enterprise headquartered in Henderson, Nevada, focuses on the creation of medications to address a broad spectrum of health conditions. Its research and development efforts target serious diseases including HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, and diabetes.
- CEO
- Dimitar Slavchev Savov
- IPO
- 2024
- HQ
- Henderson, NV, US
Price Chart
- Market Cap
- $806.33M
- P/E
- -10497.50
- P/S
- 0.00
- P/B
- -2592.82
- EV/EBITDA
- -10497.48
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 27.39%
- ROIC
- 24.70%
- Revenue
- $0 · 0.00%
- Net Income
- $-76,398 · 20.25%
- EPS
- $-0.00 · 0.00%
- Op Income
- $-76,398
- FCF YoY
- 42.73%
- 52W High
- $0.96
- 52W Low
- $0.20
- 50D MA
- $0.40
- 200D MA
- $0.44
- Beta
- -0.53
- Avg Volume
- 272
Get TickerSpark's AI analysis on NIKA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our NIKA coverage
Recent articles, reports, and earnings notes.
No research on NIKA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NIKA report →Similar companies
Peers in the same neighborhood.